CBT Architects
BioMed to Land $915M for Life Science Asset
A biotech company fully leases the Cambridge, Mass., property.
BioMed Realty Tops Out Boston Life Science Building
Upon the project’s completion, the tenant will occupy 600,000 square feet.
Bain Capital Signs 378 KSF Office Renewal, Expansion in Boston
The investment firm will grow its footprint significantly at New England’s tallest building.
Carr Properties JV Delivers 1 MSF Trophy Tower
One Congress marks Boston’s largest new office project this year.
Berkeley Investments to Build Boston Life Science Campus
Upon completion, the mixed-use development will include R&D, laboratory and office space, plus residential units.
BioMed Realty Inks 600 KSF Lease in Cambridge
Biopharmaceutical firm Takeda will occupy an entire research and development center in Kendall Square.
Can CRE Make Cities Cooler?
Listen to the latest episode of CPE’s “Sustainability Street” podcast for an in-depth look at the urban heat island effect.
Downtown Boston Office Tower Breaks Ground
The 600-foot-tall building, One Congress, is part of The HYM Investment Group’s ambitious $1.5 billion Bulfinch Crossing redevelopment, which will deliver 2.9 million square feet of mixed-use space.
Boston’s 121 Seaport: Behind the Signature Design
The high-rise has an elliptical silhouette, shaped by the need to avoid building over the transit tunnel and to reduce wind drag. Phil Casey, principal at CBT Architects, shares details of the design process, along with some current office trends.
Revitalizing Buildings in Boston: Thriving on Authenticity
CBT Architects Principal & Director of Asset Strategy Haril Pandya discusses the intricate process of revitalizing buildings in Boston and reveals efficient ways of breathing new life into old buildings.